Cargando…
The prognostic value of morphometrical features and cellular DNA content in cis-platin treated late ovarian cancer patients.
In 73 CAP-1 treated stage III and IV ovarian cancers, the prognostic significance of morphometric features and cellular DNA content has been evaluated in comparison with histologic type, grade of differentiation and a number of clinical characteristics. Borderline tumours were excluded from the stud...
Autores principales: | Baak, J. P., Schipper, N. W., Wisse-Brekelmans, E. C., Ceelen, T., Bosman, F. T., van Geuns, H., Wils, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246384/ https://www.ncbi.nlm.nih.gov/pubmed/3395555 |
Ejemplares similares
-
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
por: Kumar, Smriti, et al.
Publicado: (2011) -
Dendrimers Bind Antioxidant Polyphenols and cisPlatin Drug
por: Abderrezak, Amine, et al.
Publicado: (2012) -
Interactions of doxorubicin and cis-platin in squamous carcinoma cells in culture.
por: Kohno, N., et al.
Publicado: (1988) -
On the Mechanism of Action of the Antitumor Drug cis-Platin
(cis-DDP) and its Second Generation Derivatives
por: Aletras, Vasilis, et al.
Publicado: (1995) -
CIS-platin increases immune activity of monocytes and cytotoxic T-cells in a murine model of epithelial ovarian cancer
por: Hopkins, Daniel, et al.
Publicado: (2021)